SBC Medical Group Holdings Incorporated (SBC) P/E Ratio History
Deep ValueTrading at 6.5x · 10th percentile of 5-year range · Significant discount to historical valuation · Data 2023–2026
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, SBC Medical Group Holdings Incorporated (SBC) trades at a price-to-earnings ratio of 6.5x, with a stock price of $3.26 and trailing twelve-month earnings per share of $0.40.
The current P/E is 59% below its 5-year average of 15.9x. Over the past five years, SBC's P/E has ranged from a low of 6.3x to a high of 35.6x, placing the current valuation at the 10th percentile of its historical range.
Compared to the Industrials sector median P/E of 26.6x, SBC trades at a 76% discount to its sector peers. The sector includes 400 companies with P/E ratios ranging from 0.1x to 198.6x.
Relative to the broader market, SBC trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SBC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SBC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
SBC P/E vs Peers
Operations and human capital consulting peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $927M | 10.2Lowest | 1.03 | -36% | |
| $144B | 51.4 | 2.36 | +23% | |
| $52B | 49.6 | 7.01 | -74% | |
| $17B | 30.5 | - | -25% | |
| $12B | 22.0 | 0.71Best | +423%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
SBC Historical P/E Data (2023–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $4.18 | $0.39 | 10.6x | -33% |
| FY2025 Q4 | Dec 31 2025 | $4.31 | $0.49 | 8.7x | -45% |
| FY2025 Q3 | - | $4.34 | $0.42 | 10.4x | -35% |
| FY2025 Q2 | Jun 30 2025 | $4.64 | $0.33 | 14.2x | -11% |
| FY2025 Q1 | Mar 31 2025 | $3.19 | $0.50 | 6.3x | -60% |
| FY2024 Q4 | - | $5.56 | $0.49 | 11.3x | -29% |
| FY2024 Q3 | Sep 30 2024 | $7.97 | $0.58 | 13.7x | -14% |
| FY2024 Q2 | Jun 30 2024 | $13.07 | $0.64 | 20.4x | +29% |
| FY2024 Q1 | Mar 31 2024 | $12.70 | $0.46 | 27.6x | +73% |
| FY2023 Q4 | Dec 31 2023 | $10.77 | $0.30 | 35.6x | +124% |
Average P/E for displayed period: 15.9x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SBC — Frequently Asked Questions
Quick answers to the most common questions about buying SBC stock.
What is SBC's P/E ratio?
SBC Medical Group Holdings Incorporated (SBC) trailing twelve-month P/E ratio is 6.5x, based on TTM diluted EPS of $0.40. The 5-year average P/E is 15.9x and the historical range spans 6.3x to 35.6x.
Is SBC stock overvalued or undervalued?
SBC trades at 6.5x P/E, below its 5-year average of 15.9x. At the 10th percentile of its historical range (6.3x–35.6x), the stock is priced at a discount to its own history.
Is SBC stock expensive?
No, SBC is not expensive on a historical basis. The current P/E of 6.5x is below the 5-year average of 15.9x and sits at the 10th percentile of its valuation range.
What is SBC's historical P/E range?
Over the past 5 years, SBC's P/E ratio has ranged from 6.3x to 35.6x, with a median of 13.7x and an average of 15.9x. The current P/E of 6.5x places the stock at the 10th percentile of this range. Full historical data spans 2023–2026.
How does SBC's P/E compare to the S&P 500?
SBC trades at 6.5x P/E versus the S&P 500 median of 25.3x. The 74% discount to the market suggests lower growth expectations or perceived higher risk.
How does SBC's valuation compare to Industrials peers?
SBC Medical Group Holdings Incorporated P/E of 6.5x compares to the Industrials sector median of 26.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is SBC's PEG ratio?
SBC PEG ratio is N/A, based on a P/E of 6.5x and EPS growth of 4.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is SBC's earnings yield?
SBC earnings yield is 15.34%, the inverse of its 6.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.